196 related articles for article (PubMed ID: 27784363)
1. [Quantitation of Circulating Cell-free DNA in Patients with Lymphoma and Its Clinical Significance].
Chen YY; Guo SQ; Li YH; Wang DM; Liu X; Zhang YX; Wang SY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1390-1396. PubMed ID: 27784363
[TBL] [Abstract][Full Text] [Related]
2. The analysis of cell-free DNA concentrations and integrity in serum of initial and treated of lymphoma patients.
Wu J; Tang W; Huang L; Hou N; Wu J; Cheng X; Ma D; Qian P; Shen Q; Guo W; Peng W; Liu Y; Jiang C; Feng J
Clin Biochem; 2019 Jan; 63():59-65. PubMed ID: 30292543
[TBL] [Abstract][Full Text] [Related]
3. Cell-Free DNA in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis.
Spindler KG; Boysen AK; Pallisgård N; Johansen JS; Tabernero J; Sørensen MM; Jensen BV; Hansen TF; Sefrioui D; Andersen RF; Brandslund I; Jakobsen A
Oncologist; 2017 Sep; 22(9):1049-1055. PubMed ID: 28778958
[TBL] [Abstract][Full Text] [Related]
4. The value of fluorimetry (Qubit) and spectrophotometry (NanoDrop) in the quantification of cell-free DNA (cfDNA) in malignant melanoma and prostate cancer patients.
Ponti G; Maccaferri M; Manfredini M; Kaleci S; Mandrioli M; Pellacani G; Ozben T; Depenni R; Bianchi G; Pirola GM; Tomasi A
Clin Chim Acta; 2018 Apr; 479():14-19. PubMed ID: 29309771
[TBL] [Abstract][Full Text] [Related]
5. Temporal patterns of circulating cell-free DNA (cfDNA) in a newborn piglet model of perinatal asphyxia.
Manueldas S; Benterud T; Rueegg CS; Garberg HT; Huun MU; Pankratov L; Åsegg-Atneosen M; Solberg R; Escobar J; Saugstad OD; Baumbusch LO
PLoS One; 2018; 13(11):e0206601. PubMed ID: 30475817
[TBL] [Abstract][Full Text] [Related]
6. Quantification of plasma cell-free DNA levels in dogs with various tumors.
Tagawa M; Shimbo G; Inokuma H; Miyahara K
J Vet Diagn Invest; 2019 Nov; 31(6):836-843. PubMed ID: 31585514
[TBL] [Abstract][Full Text] [Related]
7. Plasma cell-free DNA is a prognostic biomarker for survival in patients with aggressive non-Hodgkin lymphomas.
Hur JY; Kim YJ; Yoon SE; Son DS; Park WY; Kim SJ; Park D; Kim WS
Ann Hematol; 2020 Jun; 99(6):1293-1302. PubMed ID: 32296914
[TBL] [Abstract][Full Text] [Related]
8. Alter circulating cell-free DNA variables in plasma of ovarian cancer patients.
Yu Z; Qin S; Wang H
J Obstet Gynaecol Res; 2019 Nov; 45(11):2237-2242. PubMed ID: 31502389
[TBL] [Abstract][Full Text] [Related]
9. Plasma cell-free DNA level and its integrity as biomarkers to distinguish non-small cell lung cancer from tuberculosis.
Leng S; Zheng J; Jin Y; Zhang H; Zhu Y; Wu J; Xu Y; Zhang P
Clin Chim Acta; 2018 Feb; 477():160-165. PubMed ID: 29113814
[TBL] [Abstract][Full Text] [Related]
10. Circulating cell-free DNA in plasma of colorectal cancer patients - A potential biomarker for tumor burden.
Bhangu JS; Taghizadeh H; Braunschmid T; Bachleitner-Hofmann T; Mannhalter C
Surg Oncol; 2017 Dec; 26(4):395-401. PubMed ID: 29113658
[TBL] [Abstract][Full Text] [Related]
11. Quantification of circulating cell-free DNA (cfDNA) in urine using a newborn piglet model of asphyxia.
Rajar P; Åsegg-Atneosen M; Saugstad OD; Solberg R; Baumbusch LO
PLoS One; 2019; 14(12):e0227066. PubMed ID: 31891615
[TBL] [Abstract][Full Text] [Related]
12. Increased Plasma Circulating Cell-Free DNA Could Be a Potential Marker for Oral Cancer.
Lin LH; Chang KW; Kao SY; Cheng HW; Liu CJ
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30352977
[TBL] [Abstract][Full Text] [Related]
13. Circulating cell-free DNA as a promising biomarker in patients with gastric cancer: diagnostic validity and significant reduction of cfDNA after surgical resection.
Kim K; Shin DG; Park MK; Baik SH; Kim TH; Kim S; Lee S
Ann Surg Treat Res; 2014 Mar; 86(3):136-42. PubMed ID: 24761422
[TBL] [Abstract][Full Text] [Related]
14. Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy.
Coco S; Alama A; Vanni I; Fontana V; Genova C; Dal Bello MG; Truini A; Rijavec E; Biello F; Sini C; Burrafato G; Maggioni C; Barletta G; Grossi F
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28492516
[TBL] [Abstract][Full Text] [Related]
15. Serum cell-free DNA concentration as a possible prognostic marker in newly diagnosed diffuse large B-cell lymphoma.
Shirouchi Y; Mishima Y; Takayama T; Minowa S; Ishihara Y; Tamba M; Hirano M; Onda N; Takeuchi K; Maruyama D
Biomed Res; 2022; 43(4):99-106. PubMed ID: 35989290
[TBL] [Abstract][Full Text] [Related]
16. Highly sensitive and specific real-time PCR by employing serial invasive reaction as a sequence identifier for quantifying EGFR mutation abundance in cfDNA.
Xiang Z; Wan R; Zou B; Qi X; Huang Q; Kumar S; Pitman JL; Zhou G; Song Q
Anal Bioanal Chem; 2018 Oct; 410(26):6751-6759. PubMed ID: 30128808
[TBL] [Abstract][Full Text] [Related]
17. A novel Alu-based real-time PCR method for the quantitative detection of plasma circulating cell-free DNA: sensitivity and specificity for the diagnosis of myocardial infarction.
Lou X; Hou Y; Liang D; Peng L; Chen H; Ma S; Zhang L
Int J Mol Med; 2015 Jan; 35(1):72-80. PubMed ID: 25374065
[TBL] [Abstract][Full Text] [Related]
18. Quantification of Circulating Free DNA as a Diagnostic Marker in Gall Bladder Cancer.
Kumari S; Tewari S; Husain N; Agarwal A; Pandey A; Singhal A; Lohani M
Pathol Oncol Res; 2017 Jan; 23(1):91-97. PubMed ID: 27475647
[TBL] [Abstract][Full Text] [Related]
19. Cell Free DNA and Procalcitonin as Early Markers of Complications in ICU Patients with Multiple Trauma and Major Surgery.
Ahmed AI; Soliman RA; Samir S
Clin Lab; 2016 Dec; 62(12):2395-2404. PubMed ID: 28164563
[TBL] [Abstract][Full Text] [Related]
20. Plasma Cell-Free DNA as a Predictive Marker after Radiotherapy for Hepatocellular Carcinoma.
Park S; Lee EJ; Rim CH; Seong J
Yonsei Med J; 2018 Jun; 59(4):470-479. PubMed ID: 29749129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]